Warning: Illegal string offset 'EN' in /var/www/web215/htdocs/findmulti/languages/en/terms.inc on line 1190 Warning: Illegal string offset 'EN' in /var/www/web215/htdocs/findmulti/languages/en/terms.inc on line 1194 Supplier Profile | IMGM Laboratories GmbH

Company Profile: IMGM Laboratories GmbH

General Profile | Applications
Company logo & address

IMGM Comapany Logo

IMGM Laboratories GmbH
Bunsenstrasse 7a
82152 Martinsried
Company view & branch

IMGM Company View

IMGM is one of Europe’s leading outsourcing companies, offering advanced genomic services tailored to the needs of customers from pharma, biotech and academia.

IMGM was founded in 2001 and is located on the biotech campus Martinsried, close to Munich.

At IMGM, we combine state-of-the-art technology with complex data analysis to deliver meaningful results in an easy-to-understand format.

Customer satisfaction is our definition of success

Products & special subjects

IMGM is DAkkS accredited according to DIN EN ISO/IEC 17025 specifically including an accreditation for gene expression analysis using real-time PCR and microarray technologies. Furthermore, IMGM was appointed as certified service provider for the Agilent DNA microarray platform, the Ion Torrent Personal Genome Machine (PGM) and is an Affymetrix authorized service provider for the DMET Plus Genotyping system for pharmacogenetic analyses.


RNA Services
• Whole genome microarray screening (Agilent and Affymetrix platforms)
• Gene expression studies (TaqMan qPCR, AB ViiA7 system, TaqMan arrays in 96- and 384-well format)
• microRNA profiling (Agilent microarrays, TaqMan qPCR)
• Absolute quantitation of target sequences (e.g. biodistribution studies)
• Next generation sequencing (NGS)
(Roche 454 GS FLX+ and Junior, Ion Torrent PGM, Illumina MiSeq)
• RNA isolation and quality control service (e.g. Agilent Bioanalyzer)

DNA Services
• Next Generation Sequencing (NGS)
(Roche 454 GS FLX+ and Junior, Ion Torrent PGM, Illumina MiSeq)
• NGS target enrichment (amplification- and hybridization-based)
• Metagenomics and microbial diversity (NGS-based)
• Standard Sanger DNA sequencing (AB 3730XL)
• CNV analysis using oligo array-CGH
• CNV validation with TaqMan copy number assays
• SNP genotyping (Affymetrix arrays, Pyrosequencing, Sanger sequencing, TaqMan assays)
• Absolute quantitation of target sequences (e.g. biodistribution studies)
• High-resolution HLA typing
• Pharmacogenetics (e.g. Affymetrix DMET Plus array, TaqMan assays)

Bioinformatics Services
• Full data analysis support for all applications
• Professional assay design service (e.g. qPCR, NGS)
• Identification and validation of biomarkers

• Development and optimization of diagnostic tests
• Development of next generation sequencing applications
• Performance optimization of instruments
• Quality control studies
• Biostatistics

Company history

IMGM is best known for its RNA SERVICES (microarrays, qPCR), DNA SERVICES (next generation sequencing, metagenomics, pharmacogenetics, SNP detection, assay design) and BIOINFORMATICS (supporting all our applications).

IMGM’s flexible outsourcing solutions are best characterized by:
• Dedicated team of highly trained professionals
• In-depth project consulting
• Latest methods and technologies
• Option to order any or all workflow modules
• Professional quality management
• High quality data and valid results
• Complete and understandable reports
• Professional business relationship (NDAs, FSAs, TATs etc.)
• Personal project manager and direct communication
• Long track record for customer satisfaction and project success

Experience, motivation and a strong background in molecular genetics and medical diagnostics lie at the heart of IMGM’s high quality services.

Staff & responsibilities
Name:Dr. Aljoscha Kleinhammer
responsible for:Sales and Marketing
Phone:+49 89 4524667 0
Fax:+49 89 4524667 410

Reference customers



Julia Vogt, MSC, Institute for Human Genetics, University Ulm:

The IMGM team supported us in performing a custom made aCGH. As it was the first time for me to design a custom array, I had many questions which were competently and patiently answered by the IMGM team.
In the meantime, we have performed the same custom array another two times and were very pleased with the structured procedure of data generation and analysis. Also reanalysis concerning a specific question was never a problem. Last time, I was even informed about the progress of our project which was very helpful to plan the further steps.


Jürgen Friedrichs, Director Method Integration Siemens Healthcare Diagnostics:

The IMGM team supported our research & development activities in competent, reliable and effective manner. All deliverables showed up on-time. It was fun to work with these guys.


Anders Lonneborg, Research Director, DiaGenic ASA:

We selected IMGM for our initial development of a blood-based test for the early detection of Alzheimer’s disease. The high quality and control at all steps of the work at IMGM was essential for the development of our first CE-approved test, ADtect, and we would not hesitate to entrust them with further projects in the future.


Michael Abend, Deputy Director, Bundeswehr Institute of Radiobiology:

The IMGM team proved its competence in several very diverse scientific projects. One of those was the detection of a gene signature which allows us to discriminate radiation-associated papillary thyroid cancers from sporadic thyroid cancer occurring due to other reason (Chernobyl-project).
These people do listen and are making thoughtful suggestions before the start of a project. They clearly point to the pros/cons. We do feel very comfortable with a competent partner like them who reliably help accelerating our research.


Ansgar Brüning, University Hospital Munich (LMU):

I have had two different gene expression projects performed by IMGM and each time they proved to be very professional and reliable. They will definitely be my first choice for future projects.


Stephan Brand, MD, University Hospital Munich (LMU):

The very competent IMGM team supported us in a number of projects including gene expression microarrays. The cooperation was excellent and the results were provided in time with a very valuable bioinformatics package including pathway analyses. We could confirm all top hits of the microarray analyses by quantitative PCR. The highly professional and reliable IMGM team will be our partner for future microarray experiments.